The present study is aimed to compare survival and prognostic changes over time between elderly (70–84 years) and middle-aged cancer patients (55–69 years). We considered seven cancer sites (stomach, colon, breast, cervix and corpus uteri, ovary and prostate) and all cancers combined (but excluding prostate and non-melanoma skin cancers). Five-year relative survival was estimated for cohorts of patients diagnosed in 1988–1999 in a pool of 51 European populations covered by cancer registries. Furthermore, we applied the period-analysis method to more recent incidence data from 32 cancer registries to provide 1- and 5-year relative survival estimates for the period of follow-up 2000–2002.
A significant survival improvement was observed from 1988 to 1999 for all cancers combined and for every cancer site, except cervical cancer. However, survival increased at a slower rate in the elderly, so that the gap between younger and older patients widened, particularly for prostate cancer in men and for all considered cancers except cervical cancer in women. For breast and prostate cancers, the increasing gap was likely attributable to a larger use of, respectively, mammographic screening and PSA test in middle-aged with respect to the elderly. In the period analysis of the most recent data, relative survival was much higher in middle-aged patients than in the elderly. The differences were higher for breast and gynaecological cancers, and for prostate cancer. Most of this age gap was due to a very large difference in survival after the 1st year following the diagnosis. Differences were much smaller for conditional 5-year relative survival among patients who had already survived the first year.
The increase of survival in elderly men is encouraging but the lesser improvement in women and, in particular, the widening gap for breast cancer suggest that many barriers still delay access to care and that enhanced prevention and clinical management remain major issues.
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to European Journal of Cancer
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
- Cancer burden in the aged: an epidemiologic and demographic overview.Cancer. 1997; 80: 1273-1283
Health for All database (HFA-DB), Copenhagen, WHO Regional Office for Europe (<http://www.euro.who.int/hfadb>); November 2007.
Ferlay J, Bray F, Pisani P, Parkin DM. GLOBOCAN 2002 cancer incidence, mortality and prevalence worldwide. IARC CancerBase No. 5, version 2.0. Lyon: IARC Press; 2004.
- Cancer survival in the elderly: effects of socio-economic factors and health care system features.Eur J Cancer. 2006; 42: 234-242
- Socio-economic factors and health care system characteristics related to cancer survival in the elderly. A population-based analysis in sixteen European countries.Crit Rev Oncol Hemat. 2005; 54: 117-128
- Who cares for older adults? Workforce implications of an aging society.Health Aff (Millwood) Sep–Oct. 2002; 21: 78-89
- Survival for eight major cancers and all cancers combined for European adults diagnosed in 1995–99 results of the EUROCARE-4 study.Lancet Oncol. 2007; 8: 773-783
- Recent cancer survival in Europe a 2000-02 period analysis of EUROCARE-4 data.Lancet Oncol. 2007; 8: 784-796
- Geriatric oncology: a new subspecialty.J Clin Oncol. 2004; 186: 4655
- Insight into the treatment of cancer in older patients: developments in the last decade.Cancer Treatment Rev. 2006; 32: 277-288
- Prognostic impact of increasing age and co-morbidity in cancer patients: a population-based approach.Crit Rev Oncol Hemat. 2005; 55: 231-240
- A wide difference in cancer survival between middle aged and elderly patients in Europe.Int J Cancer. 2007; 120: 2196-2201
- A computer program package for relative survival analysis.Comp Prog Biomed. 1985; 19: 197-207
- An alternative approach to monitoring cancer patient survival.Cancer. 1996; 78: 2004-2010
- Epidemiology research in ageing: perspectives and limitations.in: Balducci L. Lyman G.H. Ershler W.B. Geriatric oncology. Harwood Academic Publication, Amsterdam1998: 105-114
- Standard cancer population for estimating age standardising survival ratios.Eur J Cancer. 2004; 40: 2307-2316
- Relative survival in elderly cancer patients in Europe.Eur J Cancer. 1998; 34: 2264-2270
- Toward a comparison of survival in American and European cancer patients.Cancer. 2000; 89: 893-900
- Does cancer survival differ for older patients?.Cancer. 1992; 70: 2734-2740
- Clinical and demographic predictors of late-stage cervical cancer.Arch Fam Med. 2000; 9: 439-445
- Comorbidity in older surgical cancer patients: influence on patient care and outcome.Eur J Cancer. 2007; 43: 2179-2193
- Which comorbid conditions predict complications after surgery for colorectal cancer?.World J Surg. 2007; 31: 192-199
- Introduction: cancer in the elderly.Semin Oncol. 2004; 31: 125-127
- Progress in the treatment of breast cancer in the elderly.Ann Oncol. 2002; 13: 207-210
- Time trends of breast cancer survival in Europe in relation to incidence and mortality.Int J Cancer. 2006; 119: 2417-2422
- Effect of screening and adjuvant therapy on mortality from breast cancer.N Engl J Med. 2005; 353: 1784-1792
- Screening for colorectal, breast, and cervical cancer in the elderly: a review of the evidence.Am J Med. 2005; 118: 1078-1086
- Seventy-five years is an appropriate upper age limit for population based mammography screening.Int J Cancer. 2006; 118: 2020-2025
- Undertreatment strongly decreases prognosis of breast cancer in elderly women.J Clin Oncol. 2003; 21: 3580-3587
- Are the elderly receiving appropriate therapy for cancer?.Ann Oncol. 1996; 7: 657-658
- The influence of age and comorbidity on receiving radiotherapy as part of primary treatment for cancer in South Netherlands, 1995 to 2002.Cancer. 2006; 106: 2734-2742
- Non-standard management of breast cancer increases with age in the UK: a population based cohort of women >65 years.Brit J Cancer. 2007; 96: 1197-1203
- Adjuvant therapy in the elderly: making the right decision.J Clin Oncol. 2007; 25: 1870-1875
- Adjuvant treatment for elderly patients with stage III colon cancer in the southern Netherlands is affected by socioeconomic status, gender, and comorbidity.Ann Oncol. 2005; 16: 767-772
- Critical Review of the management of early-stage breast cancer in elderly women.Int Med J. 2007; 37: 181-189
- Prevalence of prostate specific antigen testing for prostate cancer in elderly men.J Urol. 2006; 175: 2078-2082
- Rising incidence of prostate cancer in Scotland: increased risk or increased detection?.Brit J Urol Int. 2000; 85: 463-472
- Underrepresentation of patients 65 years of age or older in cancer-treatment trials.N Engl J Med. 1999; 341: 2061-2067
- Never too old? Age should not be a barrier to enrollment in cancer clinical trials.The Oncologist. 2005; 10: 198-204
- Comprehensive geriatric assessment adds information to ECOG performance status in elderly cancer patients: an Italian group for geriatric oncology study.J Clin Oncol. 2002; 20: 494-502
- Age-related variations in progression of cancer at diagnosis and completeness of cancer registry data.Surgical Oncol. 2005; 13: 175-179
- Are there socioeconomic gradients in the quality of data held by registries?.J Epidemiol Community Health. 2004; 58: 1052-1053
- Relative survival in elderly European cancer patients: evidence for health care inequalities.Crit Rev Oncol Hemat. 2000; 35: 161-179
Published online: January 05, 2009
Accepted: November 4, 2008
Received in revised form: September 25, 2008
Received: June 4, 2008
© 2008 Elsevier Ltd. Published by Elsevier Inc. All rights reserved.